We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company

Delisted

LJPC was delisted on the 19th of August, 2022.

53 hedge funds and large institutions have $266M invested in La Jolla Pharmaceutical Company in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 6

163% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 8

128% more call options, than puts

Call options by funds: $2.24M | Put options by funds: $981K

44% more capital invested

Capital invested by funds: $184M → $266M (+$81.9M)

33% more funds holding

Funds holding: 4053 (+13)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
53
Holders Change
+13
Holders Change %
+32.5%
% of All Funds
1.43%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
21
Increased
22
Reduced
6
Closed
8
Calls
$2.24M
Puts
$981K
Net Calls
+$1.26M
Net Calls Change
+$1.55M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
26
Panagora Asset Management
Massachusetts
$730K +$142K +6,892 +30%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$517K +$435K +21,102 New
TI
28
Trexquant Investment
Connecticut
$475K +$400K +19,400 New
TCIM
29
TIAA CREF Investment Management
New York
$461K +$388K +18,828 New
NPC
30
National Planning Corporation
California
$446K
TA
31
Teachers Advisors
New York
$412K +$347K +16,817 New
Charles Schwab
32
Charles Schwab
California
$407K +$342K +16,579 New
Group One Trading
33
Group One Trading
Illinois
$357K +$300K +14,577 New
UBS Group
34
UBS Group
Switzerland
$307K +$190K +9,221 +280%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$236K +$198K +9,620 New
MLICM
36
Metropolitan Life Insurance Company (MetLife)
New York
$216K +$182K +8,820 New
NFA
37
Nationwide Fund Advisors
Ohio
$182K +$153K +7,428 New
BA
38
BlackRock Advisors
Delaware
$181K +$126K +6,095 +476%
AIG
39
American International Group
New York
$171K +$140K +6,771 +3,386%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$149K +$125K +6,078 New
Wells Fargo
41
Wells Fargo
California
$89K +$52.3K +2,539 +228%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$82K +$16.9K +822 +33%
Invesco
43
Invesco
Georgia
$73K +$61.6K +2,991 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$23.6K +$19.8K +961 New
TRCT
45
Tower Research Capital (TRC)
New York
$22K +$18.1K +878 +3,658%
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$22K +$18.1K +880 New
Bank of America
47
Bank of America
North Carolina
$8K +$6.53K +317 New
BlackRock
48
BlackRock
New York
$7K +$6.04K +293 New
Citigroup
49
Citigroup
New York
$5K +$3.98K +193 +1,072%
Barclays
50
Barclays
United Kingdom
$5K +$4.55K +221 New

LJPC Hedge Fund Activity: Q2 2015 in Review

53 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q2 2015, worth a combined $266M — up 44% from $184M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new LJPC positions and 8 closed out — a net gain of 13 holders — while 22 added to existing stakes and 6 trimmed.

The largest buyer was Tang Capital Management, adding an estimated $10.7M. The largest seller was RTW Investments, cutting an estimated $16.1M.

  • 53 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q2 2015, up from 40 in Q1 2015.
  • Funds reported $266M of La Jolla Pharmaceutical Company stock for Q2 2015, up 44% quarter-over-quarter.
  • 21 funds opened new La Jolla Pharmaceutical Company positions in Q2 2015 and 8 closed out, a net change of +13 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q2 2015 was Tang Capital Management, an estimated $10.7M added.
  • The largest La Jolla Pharmaceutical Company seller in Q2 2015 was RTW Investments, an estimated $16.1M sold.

Based on aggregated 13F filings for Q2 2015.